2.Hepatoprotective effect of Lingzhi extract on CCl4-induced hepatic lesion
Journal of Medicinal Materials - Hanoi 2005;10(3):88-92
Study on hepatoprotective effects of lingzhi extract on CCl4-induced hepatic lesion, lingzhi formulation produced by OPC Company which reached standards at basic level. Lingzhi dry powder was prepared with distilled water to make liquid extract with concentrations of 15% (15g dry extract/100ml water), 30% and 75%. These liquid extracts were used to test hepatoprotective effects. With low dose CCl4 (0,25%) induced hepatic toxication, 15%, 30% and 75% lingzhi extracts showed hepatoprotective effect. However, with high dose CCl4 (1%), only 30% lingzhi extract showed clear and stable hepatoprotective effects. Experimental trials on hepatic diseases as well as on hepatoprotective medications should provide necessary information on physiopathological characteristics and medicinal therapies
Drugs, Chinese Herbal
;
Liver
3.Q-marker prediction of Magnoliae Officinalis Cortex before and after "sweating".
Chang LIU ; Xiao WANG ; Fang LIU ; Hui-Ling HU ; Shao-Yang LIU ; Xiao LUO ; Chao-Mei FU ; Bin DENG
China Journal of Chinese Materia Medica 2021;46(11):2686-2690
Magnoliae Officinalis Cortex, a common Chinese medicinal in clinic, should undergo "sweating" process in producing area according to Chinese Pharmacopoeia, which affects its genuineness and quality. In light of the concept and research mode of quality marker(Q-marker) for decoction pieces, the active components of Magnoliae Officinalis Cortex pieces which altered significantly before and after "sweating" were identified in this study. The main pharmacodynamic material basis was clarified by pharmacodynamic, pharmacokinetic and drug property research, followed by the prediction of Q-markers of Magnoliae Officinalis Cortex before and after "sweating", for better improving its quality standard.
Drugs, Chinese Herbal
;
Magnolia
4.Bibliometric analysis and quality assessment of clinical evidence on Xiaotong Tiegao.
Sai-Nan FANG ; Bao-Jun WEI ; Chuan-Qi TANG ; Jian-Min WEN ; Xue BAI ; Si-Hong YANG ; Ying-Jie GUAN ; Yan-Ming XIE ; Wei CHEN
China Journal of Chinese Materia Medica 2019;44(20):4360-4365
Many clinical studies on Cheezheng Xiaotong Tiegao have been accumulated since it was launched in 1993,but they have not been comprehensively analyzed and evaluated. This study systematically retrieved relevant studies in six databases at home and abroad as of December 2017. This study analyzed the statistics of the included studies in several aspects,including publication time,region,fund,disease category and type of study. In this study,various tools were used to evaluate the methodological quality of included studies,such as the Cochrane collaboration's tool for assessing the risk of bias in randomized trials,MINORS,IHE,AMSTAR2.The results showed that the literatures were mainly published from 2010 to 2011,and a total of 28 projects were financially supported.The most involved disease was arthropathy. The randomized controlled trials were the majority in the included studies,but the quality was low,and most of the literatures didn't report the allocation concealment and blinding. This study comprehensively reflected the current situations and shortcomings of the clinical studies of Cheezheng Xiaotong Tiegao,and put forward several suggestions,in the expectation of providing a reference for the future clinical research direction of Cheezheng Xiaotong Tiegao.
Bibliometrics
;
Drugs, Chinese Herbal
6.Traditional Chinese medicine properties and traditional Chinese medicine property-matteromics.
China Journal of Chinese Materia Medica 2008;33(14):1769-1771
Theory of traditional Chinese medicine (TCM) properties, the essence of TCM theories, is the treasure for the Chinese nation, even for the world. It's an emergency to illustrate this theory in modernizing meaning so as to share it, one of the achievements in the Chinese civilization, for all the people in this world. TCM property-matteromics, the new concept in this article, is reported at the first time. Defined as the science of studying composition of the basic materials expressing TCM properties, correlation and interact between these materials, TCM property-matteromics was presented here in expounding the basic concept, the object, content and method of study, in order to apply a new thinking and new methodology for the TCM modernization by elucidating the essence of the theory of the TCM property.
Drugs, Chinese Herbal
;
Medicine, Chinese Traditional
;
methods
8.Brief introduction of geo-authentic herbs.
Fei LIANG ; Jian LI ; Wei ZHANG ; Rui-Xian ZHANG
China Journal of Chinese Materia Medica 2013;38(9):1455-1457
The science of geo-authentic herbs is a characteristic discipline of traditional Chinese medicine established during thousands of years of clinical practices. It has a long history under the guidance of profound theories of traditional Chinese medicine. The words of "geo-authentic product" were derived from an administrative division unit in the ancient times, which layed stress on the good quality of products in particular regions. In ancient records of traditional Chinese medicine, the words of "geo-authentic product" were first found in Concise Herbal Foundation Compilation of the Ming dynasty, and the words of "geo-authentic herbs" were first discovered in Peony Pavilion of the late Ming dynasty. After all, clinical effect is the fundamental evaluation standard of geo-authentic herbs.
Drugs, Chinese Herbal
;
Medicine, Chinese Traditional
9.Research on patent quality of Chinese listed traditional Chinese medicine enterprises from R&D investment perspective.
Ya-di CAO ; Rui-Juan GONG ; Ning CHEN ; Wei LIU
China Journal of Chinese Materia Medica 2019;44(6):1284-1288
In recent years,the number of patent applications for traditional Chinese medicine( TCM) inventions has increased rapidly,but the authorization rate has declined. Listed TCM enterprises are a group of active innovators in this field,so this paper analyzes their patent quality by combining patent application and authorization with R&D investment of enterprises in order to explore a practical way to improve the quality of TCM patents. The conclusions are as follows: the R&D investment of listed TCM enterprises is insufficient and the gap between enterprises is large; the number of patent applications is within a reasonable range,but some enterprises still have abnormal patent applications,and patent quality needs to be improved; in addition,the patent operation capacity of enterprises still needs to be improved. In this phenomenon,enterprises should improve R&D investment,strengthen the level of technological innovation,improve the ability of patent operation,and consciously eliminate the output of " abnormal patents"; the patent administrative department should optimize policy direction which is beneficial to the improvement of patent quality,grasp the normal and reasonable examination scale,and jointly improve the quality of TCM patents.
Drugs, Chinese Herbal
;
Inventions
;
Medicine, Chinese Traditional
10.Urgency of clinical evaluation of traditional Chinese medicine decoction pieces.
Wen-Ke ZHENG ; Li ZHANG ; Shu-Jie ZAN
China Journal of Chinese Materia Medica 2019;44(3):624-628
Decoction piece is the basic unit of traditional Chinese medicine(TCM) prescriptions, and it is also the main material basis for clinical efficacy of TCM. The clinical efficacy of TCM decoction pieces is very important for the overall efficacy of TCM prescriptions. However, the current quality evaluation of TCM decoction pieces mainly focuses on the amount of intrinsic substances and compositions. The basic researches such as toxicology and pharmacology are deeply, but lacking with the evidences from clinical evaluation. Therefore, the current decoction pieces quality evaluation system is difficult to objectively reflect the clinical effect of traditional Chinese medicine, forming the only componential theory or blindly pursuing the large volume and heavy weight of medicine materials. The quality standard of Chinese decoction pieces is biased,with concerns that "TCM will die from Chinese medicine". Therefore, this paper proposes that it is urgent to clinically evaluate the TCM decoction pieces,and regard the clinical evaluation as a starting point and a foothold for the quality evaluation of TCM decoction pieces, based on the origin identification, origin evaluation, product evaluation, content evaluation, and harmful substance detection as an auxiliary support. Finally a new quality evaluation system for TCM decoction pieces with a clinical evaluation as the core is formed, which is composed of six steps, aiming to promote the quality improvement of TCM decoction pieces. Of course, because there is no mature experience in the clinical evaluation of TCM decoction pieces, the quality evaluation system has some challenges such as complex processes and high cost, but it is essential for maintaining the quality of medicinal materials and life safety. Therefore, it is of importance and urgency to construct and implement the quality evaluation system.
Drugs, Chinese Herbal
;
standards
;
Medicine, Chinese Traditional